Background/Aims: Aloe-emodin (1,8-dihydroxy-3-hydroxymethyl-anthraquinone), an anthraquinone active compounds, is isolated from some traditional medicinal plants such as Rheum palmatum L. and Cassia occidentalis, which induce hepatotoxicity in rats. The aim of this study was to determine potential cytotoxic effects of aloe-emodin on HepaRG cells and to define the underlying mechanism. Methods: MTT was used to evaluate cell viability. Apoptotic cell death was analyzed via Annexin V-FITC/PI double staining. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were determined by flow cytometry, while the expression of apoptosis-related proteins was determined by Western blot analysis. Results: Treatment with aloe-emodin significantly reduced cell viability and induced apoptosis in HepaRG cells in a dose-and time-dependent manner. It provoked ROS generation and depolarization of MMP in HepaRG cells when compared with controls. Aloe-emodin dose-dependently increased release of mitochondrial cytochrome c, and levels of Fas, p53, p21, Bax/Bcl-2 ratio, as well as activation of caspase-3, caspase-8, caspase-9, and subsequent cleavage of poly(ADP-ribose)polymerase (PARP). It also induced S-phase cell cycle arrest by increasing the expression of p21 and cyclin E proteins while significantly decreasing the expression of cyclin A and CDK2. Conclusion: These results suggest that aloe-emodin inhibits cell proliferation and induces apoptosis in HepaRG cells, most probably through a mechanism involving both Fas death pathway and the mitochondrial pathway by generation of ROS. These findings underscore the need for risk assessment of human exposure to aloeemodin.
Induction of Apoptosis in HepaRG Cell

Introduction
Apoptosis is a genetically-controlled process that regulates normal development and homeostasis in organisms. Two well established mechanisms involving apoptotic cell death have been characterized. These are the death receptor pathway and the mitochondria pathway [1] [2] [3] . Caspases, a family of cysteine proteases, play a critical role in apoptosis [4] . In addition, mitochondrial-dependent apoptosis is regulated principally by the Bcl-2 family proteins, such as Bax, Bcl-2 and Bak [5] . Changes in Bax/Bcl-2 ratio could result in significant activation of caspases, and lead to cell death through the mitochondrial death pathway [6] . Reactive oxygen species (ROS) are highly reactive forms of molecular oxygen, such as superoxide anion radical (O 2 • -), hydrogen peroxide (H 2 O 2 ), singlet oxygen ( 1 O 2 ), and hydroxyl radical (OH•) [7] . Basal levels of ROS serve as physiological regulators of normal cell proliferation and differentiation, but excessive production of ROS has been implicated in cell death via DNA damage-induced cell cycle arrest [8, 9] .
Aloe-emodin ( Fig. 1 ) is an anthraquinone polyphenol and a naturally active ingredient of Chinese herbs such as Cassia occidentalis, Rheum palmatum L. and Polygonum multiflorum Thunb, which are used as traditional medicines in many countries [10] [11] [12] . Recent studies have demonstrated that aloe-emodin possesses a wide range of biological and pharmacological activities, such as anticancer [13] [14] [15] , antiviral [16] , antimicrobial [17] , and anti-inflammatory effects [18] . Previous studies have revealed that aloe-emodin exhibits therapeutic effects via regulation of the expressions of protein kinase C (PKC), bcl-2, caspases and members of the mitogen-activated protein kinase (MAPK) family [19, 20] . Panigrahi et al. reported that methanol extracts of Cassia occidentalis seeds showed significant cytotoxicities in rat primary hepatocytes and HepG2 cells, indicating that aloe-emodin might be one of its main toxic components [10, 21] . In addition, aloe-emodin has been shown to be one of the primary toxic components of Rheum palmatum L which causes hepatic and renal toxicity in rats [22] . It induces DNA damage in mouse liver and kidney cells [23] .
HepaRG cells possess both the metabolic characteristics of primary human hepatocytes and growth capacity of hepatic cell lines. Studies have demonstrated that HepaRG is useful for evaluating chemically-induced hepatotoxicity after acute and/or repeated treatment with reference drugs, and a reliable surrogate of primary human hepatocytes with potential for yielding reproducible responses [24, 25] .
Currently, there are no reports in the literature on the effects of aloe-emodin on apoptosis in HepaRG cell line. The present study was aimed at evaluating the cytotoxicity of aloe-emodin in HepaRG cells and the underlying molecular mechanisms.
Materials and Methods
Cell culture conditions
HepaRG cell line was purchased from Guangzhou Jenniobio Biotechnology Co., Ltd., China. The cells were cultured in RPMI 1640 medium supplemented with 10% FBS, antibiotics (100 U/mL penicillin and 100 μg/mL streptomycin), and incubated at 37°C in a humidified atmosphere containing 5% CO 2 . For all in vitro assays, aloe-emodin was dissolved in dimethyl sulfoxide (DMSO) to a stock concentration of 40 mM and stored at 4°C. The final working concentration of DMSO in cell culture experiments did not exceed 0.1%. The working solutions were freshly diluted in the basal medium.
Chemicals and antibodies
Aloe-emodin (batch no. 111573, purity > 98.0%) was purchased from Shanghai Standard Biotech Co., Ltd., Shanghai, China. RPMI 1640 medium, penicillin, streptomycin, and fetal bovine serum (FBS) were obtained from Gibco-Life Technologies (USA). 3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium bromide (MTT) was product of Bejing Biodee Biotechnology Co. Ltd, Beijing, China. Lactate dehydrogenase (LDH), 4', 6-diamidino-2-phenylindole (DAPI), 2,7-dichlorofluorescein diacetate (DCFH-DA), N-acetylcysteine (NAC), Z-VAD-FMK, Annexin V-fluorescein isothiocyanate (FITC), apoptosis measurement kit, mitochondrial membrane potential assay kit with JC-1, cell cycle and apoptosis analysis kits were purchased from Beyotime (Nanjing, China). Reduced glutathione (GSH) was obtained from Jiancheng Bioengineering Institute (Nanjing, China). Antibodies for Fas (#4233), Bax (#5023T), Bcl-2 (#15071), p53 (#2524T), p21(#2947T), cyclin A(#4656T), CDK 2 (#2546T), cleaved caspase-3 (#9661T), cleaved caspase-9 (#9501T), cytochrome c (#4280T), and PARP (#9542T) were purchased from Cell Signaling Technology. Antibody for caspase-8 (#ab25901) was purchased from Abcam (#ab25901).
Cytotoxicity assay To investigate cell viability, HepaRG cells were seeded in 96-well plates at a density of 5 × 10 3 cells per well overnight. The cells were treated with various concentrations of aloe-emodin for 24, 48, and 72 h. DMSO (0.1%) was used as the untreated control. Then the cells were incubated with new culture medium containing MTT working solution (0.5 mg/ml) for 2h at 37°C [26] . Culture supernatant was removed from all the wells, and the formazan crystals were dissolved in DMSO. Absorbance of the formazan solution was read at 570 nm in a microplate reader (Thermo, Multiskan GO, USA). For the assay of LDH, the cells were treated with serial concentrations of aloe-emodin for 48 h. The supernatant was collected, and LDH activity was determined with a commercial kit in accordance with the manufacturer's instructions. The experiments were performed in triplicate.
DAPI staining
Morphological changes in nuclei were visualized by DNA staining with the fluorescent dye DAPI. Following incubation with various concentrations of aloe-emodin for 48 h, cells were harvested and washed once with PBS and fixed with 4% paraformaldehyde (Sigma) in PBS for 15 min at room temperature. The fixed cells were then washed with PBS and stained with a DAPI solution (2.5 μg/ml) for 10 min at room temperature. Thereafter, the cells were washed twice with PBS and nuclear changes were analyzed using an inverted Olympus IX71 fluorescence microscope (Japan).
Annexin V/PI double-staining assay
Apoptotic cells were quantified using an Annexin V-FITC detection kit and analyzed by flow cytometry [27] . In this process, HepaRG cells were seeded in 6-well plates at a density of 4 × 10 5 cells/well and treated with different concentrations of aloe-emodin for 48 h at 37°C. The cells were washed with PBS and resuspended in 295 µl binding buffer. Annexin V-FITC (5 µl) and propidium iodide (10 µl) were added, and the mixture was incubated for 15 min at 37°C in the dark. Finally, apoptotic cells were immediately analyzed by flow cytometry (BD FACSCanto II, USA).
Measurement of intracellular ROS and GSH
Intracellular accumulation of ROS was determined using fluorescent DCFH-DA [28, 29] . DCFH-DA is a stable, non-polar compound which readily diffuses into cells and is hydrolyzed by intracellular esterase to yield DCFH, which is trapped into the cells. ROS produced by the cells oxidize DCFH to highly fluorescent compound 2, 7-dichlorofluorescein (DCF). Thus, the fluorescence intensity of DCF is directly proportional to the amount of ROS produced by the cells. In this assay, HepaRG cells were plated in 6-well culture plates at a density of 4 × 10 5 cells per well. After treatment with different concentrations of aloe-emodin for 48 h, the cells were washed twice in PBS and incubated with 10 μM DCFH-DA at 37°C for 30 min. Thereafter, the cells were washed twice with PBS and re-suspended for analysis. The intensities of fluorescence were measured by flow cytometry. To test the effect of time-dependent ROS generation, HepaRG cells were seeded in 6-well culture plates (4 × 10 5 /well) and treated with 40 μM aloe-emodin for 3, 6, 12 and 24 h. After treatment with DCFH-DA (10 μM) for 30 min at 37°C in the dark, the cells were washed twice with PBS and their fluorescence images were acquired using an inverted Olympus IX71 fluorescence microscope. Furthermore, to determine the role of ROS production in aloe-emodin induced apoptosis in HepaRG cells, the cells were pre-treated with 1 μM NAC (a free radical scavenger) for 1 h and subsequently treated with 40 μM aloeemodin for 48 h. For GSH assay, HepaRG cells were incubated with various concentrations of aloe-emodin or control media treatment for 48 h, lysed and homogenized. Cell supernatant was collected and assayed for GSH content with commercially available kits (Jiancheng, Nanjing, China) in accordance with the manufacturer's instructions.
Measurement of mitochondrial membrane potential (MMP)
Mitochondrial membrane potential was measured using JC-1, which is a mitochondria-specific lipophilic cationic fluorescence dye capable of selective entrance into the mitochondria [30] . HepaRG cells were plated in 6-well culture plates at a density of 4 × 10 5 cells/ well overnight. Different concentrations of aloe-emodin were added and incubated further for 48 h. The cells were then stained with 10 μM JC-1 working solution for 30 min at 37°C in the dark, washed twice with PBS and analyzed using a flow cytometry.
Cell cycle analysis
To determine the effects of aloe-emodin on cell cycle distribution, the DNA contents of the cells were assessed by flow cytometry [31] . In the assay, the cells were incubated with various concentrations of aloe-emodin for 48 h, fixed with 70% ice-cold ethanol at 4°C overnight, and then stained with PI/RNase (a staining buffer solution) for 30 min at 37°C in the dark. The DNA content of cells and cell-cycle distribution were analyzed by flow cytometry.
Western blot analysis
After treatment with aloe-emodin, the cells were harvested and washed twice with ice-cold PBS. The cells were lysed with RIPA buffer [50 mM Tris (pH7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate and 0.1% SDS] on ice for 30 min. In a parallel experiment, the mitochondrial and cytosolic fractions were isolated using a ProteoExtract ® Cytosol/Mitochondria Fractionation Kit (Millipore) according to the manufacturer's instructions. Lysates were centrifuged at 12,000 rpm for 10 min at 4°C. For determination of protein concentration, bicinchoninic acid (BCA) protein assay kit was used according to manufacturer's instructions. An equal amount of protein was subjected to electrophoresis on sodium dodecyl sulfate (SDS)-polyacrylamide gels and transferred to a polyvinylidene fluoride (PVDF) membrane. Then, the membranes were blocked with 5% skim milk in Tris-buffered saline containing Tween-20 (TBST) for 1 h and then incubated with primary antibodies overnight at 4°C [32] . After three washes with TBST, the membranes were further incubated with horseradish peroxidase-conjugated secondary antibodies. An enhanced ECL detection system was used for visualization of target proteins (iNtRON Biotechnology, Seongnam, Korea). The experiments were repeated at least thrice.
Statistical Analysis
All assays were performed in triplicates and the results were expressed as mean ± S.D. Statistical significances were analyzed by One-Way ANOVA analysis and LSD test using the SPSS software (17.0). Differences at p < 0.05 were considered statistically significant. Each result is the mean of at least three independent experiments.
Results
Cytotoxic effect of aloe-emodin on HepaRG cells
As shown in Fig. 2A , aloe-emodin markedly reduced the viability of HepaRG cells in a dose-and time-dependent manner when compared with vehicle controls. LDH is located predominantly in cytoplasm and its presence in extracellular medium serves to detect disruption of cell membrane integrity. Thus leakage of LDH is an indication of cell membrane damage. Results showed that leakage of LDH occurred in HepaRG cells in a dose-dependent manner after treatment with different concentrations of aloe-emodin for 48 h (Fig. 2B) . Moreover, DAPI staining revealed clear morphological changes associated with apoptosis, such as condensation of chromatin and nuclear fragmentation (Fig. 2C) . 
Aloe-emodin increased apoptosis of HepaRG cells
Following treatment with aloe-emodin for 48 h, the percentage of viable cells decreased significantly. Furthermore, the percentage of early apoptotic cells increased in a dosedependent manner from 2.33 % ± 0.70 to 37.10 % ± 0.62, along with lower increases in necrotic and late apoptotic cells from 4.07 % ± 0.78 to 12.50 % ± 5.69. However, pretreatment with NAC or Z-VAD-FMK successfully reversed the apoptosis of HepaRG cells induced by aloe-emodin ( Fig. 3A and B ). These results demonstrate that apoptosis is one of the ways through which aloe-emodin induces HepaRG cell death.
Effects of aloe-emodin on intracellular ROS and GSH levels in HepaRG cells
In order to determine whether aloe-emodin induces oxidative stress, the effects of aloeemodin on ROS production and GSH levels were determined. The results showed that ROS was dose-dependently increased in HepaRG cells after treatment with aloe-emodin for 48 h, when compared with untreated cells. In addition, there were significant increases in ROS generation after treatment with 40 μM aloe-emodin for 3, 6, 12 and 24 h. However, aloeemodin-induced increases in ROS levels were significantly attenuated by pre-treatment with NAC, a ROS scavenger ( Fig. 4A and B) . As shown in Fig. 4C , compared with the control group, aloe-emodin treatment resulted in depletion of intracellular GSH levels in HL-7702 cells in a dose-dependent manner. This result shows that aloe-emodin treatment could affect cellular redox status.
Effects of aloe-emodin on MMP in HepaRG cells
To investigate whether aloe-emodin-induced apoptosis is associated with mitochondrial dysfunction, mitochondrial membrane potential was assessed using JC-1 fluorescence staining by flow cytometry. As shown in Fig. 5A and 5B, the ratio of red fluorescence intensity to green fluorescence intensity gradually decreased in a concentration-dependent manner due to the aloe-emodin treatment, indicating disruption of MMP and mitochondrial damage. Loss of MMP initiates release of cytochrome c into the cytosol, which subsequently activates a caspase cascade that results in apoptosis. Thus, we separated mitochondrial and cytosolic fractions by using ProteoExtract ® Cytosol/Mitochondria Fractionation Kit (Millipore) according to the manufacturer's instructions, and then examined the release of cytochrome c via Western blot analysis. As shown in Fig. 5C and 5D , aloe-emodin treatment caused a dosedependent decrease in the level of cytochrome c in the mitochondria and a corresponding increase in cytochrome c in the cytosol. These findings suggest that mitochondrial dysfunction is probably involved in the aloe-emodin-induced apoptosis of HepaRG cells.
Aloe-emodin induced S phase cell cycle arrest
To investigate further features of cell growth inhibition by aloe-emodin, flow cytometric analysis was performed. As shown in Fig. 6A and 6B, the accumulation of cells in the S-phase was accompanied by synchronous decreases in the numbers of cells in the G1 phase. To verify the results of the effect of aloe-emodin on the cell cycle distribution, we determined the expression levels of the relevant proteins involved in the S-phase progression. As shown in Fig. 6C and 6D , aloe-emodin treatment increased the expression of p53, p21 and cyclin E proteins while significantly decreasing the expression of cyclin A and CDK2 in HepaRG cells. These results reveal that aloe-emodin inhibited cell cycle progression via altering the expression of cell cycle regulators.
The intracellular apoptotic signaling pathway by aloe-emodin
To explore the possible mechanism of aloe-emodin-mediated apoptosis, we measured apoptosis-related protein changes using Western blot analysis. The expression of Fas, a typical death receptor, was increased after treatment with aloe-emodin for 48 h when compared with untreated cells (Fig. 7) . Furthermore, the expressions of Bax, cleaved caspase-3, -8 and -9 were significantly increased, while that of Bcl-2 decreased significantly, thereby resulting in increased ratio of Bax to Bcl-2. PARP, which is a well-known substrate of caspase-3, was also cleaved in response to aloe-emodin. These results suggest that aloe-emodin induced apoptosis in HepaRG cells via intrinsic and extrinsic apoptotic pathways dependent on caspase activation. 
Discussion
Aloe-emodin is an anthraquinone polyphenol compound present in some traditional medicinal plants such as Cassia occidentalis, Rheum palmatum L. and Polygonum multiflorum Thunb. Studies have shown that aloe-emodin has many pharmacological effects [10] [11] [12] . Some studies demonstrated that aloe-emodin might be one of the hepatotoxic components in Rheum palmatum L. and Cassia occidentalis [10, 21, 22] . Previous studies have confirmed the effectiveness of aloe-emodin in promoting anti-proliferation and apoptosis in human hepatoma cell lines through up-regulation of the expression of p53, stimulation of p21/ WAF1 and down-regulation of calpain-2 (CAPN2) and ubiquitin-protein ligase E3A (UBE3A) [33, 34] . Results from MTT showed that aloe-emodin effectively inhibited the proliferation of HepaRG cells in a dose-and time-dependent manner when compared with the control treatment. Moreover, HepaRG cells which were treated with aloe-emodin for 48 h exhibited more cytotoxicity than the 24h treatment, especially in the high dose group. Hence, treatment with aloe-emodin for 48 h was chosen for our studies. DAPI staining demonstrated that exposure of cells to aloe-emodin produced cell shrinkage and nuclear condensation, which indicated the existence of apoptosis in the HepaRG cells. In addition, aloe-emodin induced apoptotic cell death in HepaRG cells in a dose-dependent manner as evidenced by Annexin V/PI double staining, suggesting that the cytotoxic effect on HepaRG cells was mediated through the induction of apoptosis. Uncontrolled ROS production and/ or decreased antioxidant defenses result in oxidative stress, which has been considered to be an important pathogenic element for the initiation of hepatotoxicity [35] . GSH is crucial for maintaining the detoxification system because it reduces ROS and recycles antioxidants. Since aloe-emodin-induced apoptosis in HepaRG cells correlated with ROS, it was postulated that aloe-emodin treatment disturbs cellular redox status. The results of this study show that aloe-emodin treatment enhanced ROS production and down-regulated GSH levels in HepaRG cells, an indication that oxidative stress occurred following the aloe-emodin stimulus. Moreover, pre-treatment with NAC or Z-VAD-FMK almost completely reversed the apoptosis induced by aloe-emodin. Aloe-emodin exposure caused disruption of MMP in HepaRG cells and the release of cytochrome c from the mitochondria into the cytosol. The level of cytochrome c decreased in the mitochondria and correspondingly increased in the cytosol. These data indicate clearly that aloe-emodin caused mitochondrial damage in the HepaRG cells. Apoptosis can be induced either through an extrinsic pathway, which is triggered by the binding of apoptosis-inducing ligands to cell surface receptors, or through an intrinsic pathway, which is regulated by the balance between pro-apoptotic and anti-apoptotic Bcl2 proteins in the mitochondria [36] . Many studies have shown that aloe-emodin induced apoptosis in cancer cells through the Fas/death-receptor and mitochondriadependent apoptotic pathway [37, 38] . These results are consistent with the findings in the present study, which showed that aloeemodin treatment significantly increased the expressions of Fas and Bax, cleaved caspases-3, -8 and -9, and decreased the expression of Bcl-2. Further investigation revealed a dose-dependent increase in PARP cleavage in the aloe-emodin-treated cells. These data suggest that the Fas/death-receptor and caspase-dependent mitochondrial pathway are involved in the mechanism underlying the aloe-emodin-induced apoptosis of HepaRG cells. As a result, aloe-emodin can be considered to be one of the major hepatotoxic substances in the herbal medicine derived from Cassia occidentalis and Rheum palmatum L.
In conclusion, the present investigation is the first report on aloe-emodin-induced apoptosis in HepaRG cells. The results indicate that aloe-emodin inhibits cell proliferation and induces cell-cycle arrest and apoptosis through both Fas death pathway and the mitochondrial pathway (Fig. 8) . Previous studies of aloe-emodin focused on its biological activities, especially anti-cancer effects, while its toxic or side effects were often overlooked. It is hoped that the findings in this study will be helpful in providing guidelines regarding the safety of aloe-emodin for clinical administration and the development of new pharmaceuticals.
